Search

Filters

Clear Filters
5:15 PM - 5:25 PM PT

168 - Advancing 3D MRI Foundation Models for Enhanced MR Image Analysis
Speaker: Yang, Xiaofeng, PhD - Emory University, Atlanta, GA
5:25 PM - 5:35 PM PT

169 - Automating Head-and-Neck Cancer Intensity Modulated Radiation Therapy Treatment Planning with a ReAct Large Language Model Agent
Speaker: Yang, Dongrong, MS, BS - Duke University Medical Center, Durham, NC
5:35 PM - 5:45 PM PT

170 - Pediatric Radiation Oncology with Movie Induced Sedation Effect (PROMISE): A Phase II Clinical Trial to Safely Reduce Anesthesia Use
Speaker: Kumar, Kiran, MD, MBA - UT Southwestern Medical Center, Dallas, TX
4:45 PM - 4:55 PM PT

171 - Sacral Chordoma: A Randomized and Observational Study on Surgery vs. Definitive Radiotherapy in Primary Localized Disease (SACRO)
Speaker: Fossati, Piero, MD - MedAustron Ion therapy Center
4:55 PM - 5:05 PM PT

172 - The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Speaker: Nordlund, Kelsey - MD Anderson Cancer Center, Houston, TX
5:05 PM - 5:15 PM PT

173 - A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Speaker: Mitra, Devarati, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, TX
5:15 PM - 5:25 PM PT

174 - Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26
Speaker: Ioakeim-Ioannidou, Myrsini, MD - Massachusetts General Hospital, Boston, MA
5:25 PM - 5:35 PM PT

175 - Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Speaker: Yang, Noel, MS - MD Anderson Cancer Center, Houston, TX
5:35 PM - 5:45 PM PT

176 - Does Dose Avoidance of Uninvolved Skin/Subcutaneous Tissues Reduce Morbidity in Preoperative Intensity-Modulated Radiation Therapy for Soft Tissue Sarcomas of the Lower Extremity?
Speaker: Roohani, Siyer, MD - Princess Margaret Cancer Center, University Health Network, Toronto, ON
8:00 AM - 8:10 AM PT

177 - Development and Validation of a Digital Pathology-Based, Multimodal Artificial Intelligence (MMAI) Biomarker in Patients with Head and Neck Cancer
Speaker: Chinn, Steven, MD - University of Michigan, Ann Arbor, MI
8:10 AM - 8:20 AM PT

178 - Crowdsourcing Tumor Auto-Contouring Solutions for MR-Guided Radiotherapy: The HNTS-MRG 2024 Challenge
Speaker: Wahid, Kareem, PhD - MD Anderson Cancer Center
8:20 AM - 8:30 AM PT

179 - Automated Clinical Target Volume Contour Quality Assurance for the TROG 08.08 TOPGEAR Trial
Speaker: Chlap, Phillip, MS - University of New South Wales, Sydney, NSW